2. 考研
  3. The following paragraphs are given in a wrong order. For Questions 41-45, you are required to reorganize these paragraphs into a

The following paragraphs are given in a wrong order. For Questions 41-45, you are required to reorganize these paragraphs into a

admin2014-06-13  4
问题 The following paragraphs are given in a wrong order. For Questions 41-45, you are required to reorganize these paragraphs into a coherent article by choosing from the list A-G. Some of the paragraphs have been placed for you. (10 points)

A. Then came Merck’s withdrawal from the market of its blockbuster anti-inflammatory drug, Vioxx, because of an increase in side effects, including heart attacks and strokes. This led one of FDA’s medical officers, in November testimony before the Senate Finance Committee, to accuse his own colleagues of discounting recommendations from the agency’s safety researchers, and of consistently being in denial when data indicate safety problems from an approved drug.
B. The first kind of error is highly visible, causing the regulators to be attacked by the media and patient groups, and to be investigated by Congress. But the second kind of error—keeping a potentially important product out of consumers’ hands—is usually a non-event, eliciting little attention, let alone outrage.
C. The FDA is a favorite target of critics, who variously accuse regulators of excessive risk-aversion and delay of approvals, or of too cozy a relationship with the drug industry. Sen. Charles E. Grassley (R-Iowa), the chairman of the Senate Finance Committee, recently chided the agency, "The health and safety of the public must be the FDA’s first and only concern."
D. First the FDA (Food and Drug Administration) was blindsided by Chiron Corp.’s inability to provide flu vaccine this season because of contamination at its manufacturing facility, depriving Americans of half the usual supply.
E. Grassley is right, but particularly when governmental pre marketing approval of a product is required, greater safety is not synonymous with more stringent regulation. In fact, net benefit to patients often suffers because of an obscure regulatory anomaly: the asymmetry of outcomes from the two types of mistakes that regulators can make. A regulator can commit an error by permitting something bad to happen (approving a harmful product), or by preventing something good from becoming available (not approving a beneficial product). Both outcomes are bad for the public, but the consequences for the regulator are very different.
F. As a result, regulators make decisions defensively—in other words, to avoid approvals of harmful products at any cost—so they tend to delay or reject new products of all sorts, from fat substitutes to vaccines and painkillers. That’s bad for public health and for consumers’ freedom to choose.
G. Congress has a long and ignoble history of exaggerated legislative responses to perceived health crises. It seems to be at it again. Recent events have shifted the Congress into crisis mode once more.

Order: F is the first paragraph and G is the last.

选项
答案C
解析 上一段最后提到"FDA的一位医疗官员指责其自己的同事对来自机构安全研究人员的建议大打折扣，并在数据暗示一种许可药物有安全问题时不断否认"，从而可推知接下来的一段会就FDA做出相关论述，所以C项符合此处的论述，其开头提到"FDA是批评家们最喜欢的一个目标"。因此该项为此处的正确答案。
转载请注明原文地址:https://kaotiyun.com/show/4fO4777K
0

考研英语一

相关试题推荐
随机试题
最新回复(0)